✦ LIBER ✦

A phase-II trial of alltransretinoic acid and low-dose cytosine arabinoside for the treatment of high-risk myelodysplastic syndromes

✍ Scribed by A. Venditti; A. Tamburini; F. Buccisano; M. T. Scimò; G. Del Poeta; L. Maurillo; M. C. Cox; E. Abruzzese; M. Tribalto; M. Masi; S. Amadori

Publisher: Springer
Year: 2000
Tongue: English
Weight: 78 KB
Volume: 79
Category: Article
ISSN: 0939-5555
DOI: 10.1007/s002770050569

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Results of a multicenter phase II trial

Results of a multicenter phase II trial for older patients with c-Kit-positive acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (HR-MDS) using low-dose Ara-C and Imatinib

✍ Florian Heidel; Jorge Cortes; Frank G. Rücker; Walter Aulitzky; Laurie Letvak; T 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 154 KB 👁 2 views

Treatment of refractory Hodgkin's diseas

Treatment of refractory Hodgkin's disease with high-dose cytosine arabinoside and mitoxantrone in combination. Results of a clinical phase II study of the German Hodgkin study group

✍ Wolfgang Hiddemann; Norbert Schmitz; Michael Pfreundschuh; Karl-Heinz Pflüger; J 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 570 KB

A comparison of low-dose cytarabine and

A comparison of low-dose cytarabine and hydroxyurea with or without all-trans retinoic acid for acute myeloid leukemia and high-risk myelodysplastic syndrome in patients not considered fit for intensive treatment

✍ Alan K. Burnett; Donald Milligan; Archie G. Prentice; Anthony H. Goldstone; Mary 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 153 KB 👁 2 views

Salvage treatment for primary resistant

Salvage treatment for primary resistant acute myelogenous leukemia consisting of intermediate-dose cytosine arabinoside and interspaced continuous infusions of idarubicin: A phase-II study (no. 06901) of the EORTC Leukemia Cooperative Group

✍ T. De Witte; S. Suciu; D. Selleslag; B. Labar; K. Roozendaal; R. Zittoun; M. Rib 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 156 KB

A phase II multi-institutional trial of

A phase II multi-institutional trial of low-dose N-(phosphonacetyl)-L-aspartate and high-dose 5-fluorouracil as a short-term infusion in the treatment of adenocarcinoma of the pancreas. A southwest oncology group study

✍ Louise M. Morrell; Ardalan Bach; Stephen P. Richman; Phyllis Goodman; Thomas R. 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 303 KB 👁 2 views